Form 8-K - Current report:
SEC Accession No. 0001493152-24-024449
Filing Date
2024-06-20
Accepted
2024-06-20 09:30:18
Documents
37
Period of Report
2024-06-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38202
2 ex99-1.htm EX-99.1 31867
3 ex99-1_001.jpg GRAPHIC 129026
4 ex99-1_002.jpg GRAPHIC 340442
5 ex99-1_003.jpg GRAPHIC 152851
6 ex99-1_004.jpg GRAPHIC 89801
7 ex99-1_005.jpg GRAPHIC 253504
8 ex99-1_006.jpg GRAPHIC 84017
9 ex99-1_007.jpg GRAPHIC 96331
10 ex99-1_008.jpg GRAPHIC 110305
11 ex99-1_009.jpg GRAPHIC 145779
12 ex99-1_010.jpg GRAPHIC 269867
13 ex99-1_011.jpg GRAPHIC 253891
14 ex99-1_012.jpg GRAPHIC 226651
15 ex99-1_013.jpg GRAPHIC 264333
16 ex99-1_014.jpg GRAPHIC 145135
17 ex99-1_015.jpg GRAPHIC 285320
18 ex99-1_016.jpg GRAPHIC 300348
19 ex99-1_017.jpg GRAPHIC 278109
20 ex99-1_018.jpg GRAPHIC 268067
21 ex99-1_019.jpg GRAPHIC 102636
22 ex99-1_020.jpg GRAPHIC 95068
23 ex99-1_021.jpg GRAPHIC 180177
24 ex99-1_022.jpg GRAPHIC 206973
25 ex99-1_023.jpg GRAPHIC 99130
  Complete submission text file 0001493152-24-024449.txt   6263675

Data Files

Seq Description Document Type Size
26 XBRL SCHEMA FILE pvct-20240620.xsd EX-101.SCH 3027
27 XBRL LABEL FILE pvct-20240620_lab.xml EX-101.LAB 34240
28 XBRL PRESENTATION FILE pvct-20240620_pre.xml EX-101.PRE 22367
40 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3363
Mailing Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929
Business Address 800 S. GAY STREET SUITE 1610 KNOXVILLE TN 37929 (866) 594-5999
PROVECTUS BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000315545 (see all company filings)

EIN.: 900031917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36457 | Film No.: 241054384
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)